Meeting
2019 ASCO Annual Meeting
Tumor mutation burden and PD-L1 expression in SDH/FH mutated solid tumors.
Authors
Leylah Drusbosky
NantHealth, Culver City, CA
Leylah Drusbosky , Christopher Szeto , Sandeep K. Reddy , Maninderjit Ghotra , Amir A. Toor , Steven Smith , Anthony Faber , Sosipatros Alexandros Boikos
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Cancer Prevention, Hereditary Genetics, and Epidemiology
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Genetics
Citation
J Clin Oncol 37, 2019 (suppl; abstr 1524)
DOI
10.1200/JCO.2019.37.15_suppl.1524
Abstract #
1524
Poster Bd #
18
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Targetable immune checkpoint molecules may be significantly differentially expressed in minority ethnicities.
First Author: Jacob J. Adashek
Poster
2023 ASCO Annual Meeting
Exploring the potential of combination immune checkpoint strategies in non-small cell lung cancer (NSCLC).
First Author: Aakash Desai
Poster
2022 ASCO Annual Meeting
Comprehensive transcriptomic analysis of immune checkpoint markers in a pancancer cohort: Implications for response and resistance.
First Author: Hirotaka Miyashita
Poster
2022 ASCO Annual Meeting
Characterization of NY-ESO-1 gene expression in gastric cancer (GC).
First Author: Annika Lenz